Natus and Masimo Helped IHI’s Top Ten Small-Cap Stocks Outperform

What Impacted the iShares US Medical Devices ETF on October 12?

(Continued from Prior Part)

Top ten small-cap stocks outperform

The top ten small-cap stocks within the iShares Medical Devices ETF (IHI) by market cap outperformed the SPDR S&P 500 ETF (SPY) and IHI itself with an average return of 0.63%. In comparison, SPY returned 0.09% and IHI returned 0.15% on October 12, 2015. The top ten small-caps include stocks like Insulet (PODD) and Nevro (NVRO), which returned -0.3% and -2.6%, respectively. The combined weight of the top ten small-cap stocks stood at 3.8% of IHI’s portfolio. In the top ten stocks, only two stocks ended in the red while the remaining eight stocks rose.

The above graph shows the performance of the top ten small-cap stocks with IHI and SPY on October 12. The top ten small-cap stocks outperformed the top ten mid-cap and the top ten large-cap stocks.

Natus and Masimo outperformed

Masimo (MASI) rose 1.4%. The stock has been on the upward trend since Masimo PVI was evaluated for its ability to help clinicians assess fluid responsiveness. MASI closed at $40.14 and was trading above its 100-day moving average. MASI’s RSI (relative strength index) stood at 50, indicating that the stock is neither overbought nor oversold. MASI has a weight of 0.59% in IHI’s portfolio.

Natus (BABY) gained 1.9% and closed at $39.90. The stock is trading below its 20-day, 50-day, and 100-day moving averages. The stock went up on good trading volumes of ~183,000 shares as against the five-day average trading volume of ~205,000 shares per day. With its current price, the stock’s trailing-12-month price-to-equity was at 33.7x, and the price-to-book value stood at 3.5x. BABY has a weight of 0.45% in IHI’s portfolio.

Investors can indirectly invest in these stocks by investing in IHI, which also holds stocks like Stryker (SYK) and Waters (WAT), which gave returns of 0.78% and -0.27%, respectively.

Browse this series on Market Realist: